Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 13Head & Neck 3Dermatologic 3Tumor-Agnostic 2Thoracic 2Other hematologic neoplasm 2Gastrointestinal 2Other solid neoplasm 1Lymphoid 1

Conditions

Relapsed Malignant Solid Tumor 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Melatonin × Other solid neoplasm × Clear all
NCT01858155 2019-01-31

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

C17 Council

Phase 1 Completed
9 enrolled
Other solid neoplasm

Relapsed Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡